相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alpha-1 antitrypsin deficiencye-associated panniculitis
Alessandro N. Franciosi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)
SZ alpha-1 antitrypsin deficiency and pulmonary disease: more like MZ, not like ZZ
Alessandro N. Franciosi et al.
THORAX (2021)
Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis
Igor Barjaktarevic et al.
BMC PULMONARY MEDICINE (2021)
There is No Fast Track to Identify Fast Decliners in Alpha-1 Antitrypsin Deficiency by Spirometry: A Longitudinal Study of Repeated Measurements
James A. Stockley et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2021)
Pleiotropic associations of heterozygosity for the SERPINA1 Z allele in the UK Biobank
Katherine A. Fawcett et al.
ERJ OPEN RESEARCH (2021)
Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19
Oliver J. McElvaney et al.
JOURNAL OF CYSTIC FIBROSIS (2021)
The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS
Victor E. Ortega et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency
Alessandro N. Franciosi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Consequences of Abrupt Cessation of Alpha1-Antitrypsin Replacement Therapy
Oliver J. McElvaney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes
Tomoko Nakanishi et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease
Christine I. Wooddell et al.
JCI INSIGHT (2020)
Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States
Jan Sieluk et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
Robert Sandhaus et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2020)
Limitations and Challenges of Conducting Budget Impact Analyses in Rare Diseases: A Case Study of Alpha-1 Antitrypsin Deficiency
Juan-David Rueda et al.
VALUE IN HEALTH REGIONAL ISSUES (2020)
Alpha-1 Antitrypsin Deficiency and Tobacco Smoking: Exploring Risk Factors and Smoking Cessation in a Registry Population
Alessandro N. Franciosi et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2020)
The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency
Marc Miravitlles et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy A Pilot Clinical Trial
Michael A. Campos et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis
Michael A. Campos et al.
ADVANCES IN THERAPY (2018)
α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease
John M. Magenau et al.
BLOOD (2018)
Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice
Shen Shen et al.
HUMAN GENE THERAPY (2018)
Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients
Alice M. Turner et al.
JOURNAL OF HEPATOLOGY (2018)
Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype
Mikael Bjursell et al.
EBIOMEDICINE (2018)
Genotype is associated with smoking and other key health behaviors among individuals with alpha-1 antitrypsin deficiency-associated lung disease
Kristen E. Holm et al.
RESPIRATORY MEDICINE (2018)
Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits
Hanan A. Tanash et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency
Marc Miravitlles et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
Noel G. McElvaney et al.
LANCET RESPIRATORY MEDICINE (2017)
Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
Florian M. Karl et al.
RESPIRATORY RESEARCH (2017)
α-1-Antitrypsin variants and the proteinase/antiproteinase imbalance in chronic obstructive pulmonary disease
Nicola J. Sinden et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling
Ciara A. O'Dwyer et al.
JOURNAL OF IMMUNOLOGY (2015)
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial
Kenneth R. Chapman et al.
LANCET (2015)
PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD
C. E. Green et al.
THORAX (2015)
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
Cathie Sudlow et al.
PLOS MEDICINE (2015)
Z α1-Antitrypsin Confers a Proinflammatory Phenotype That Contributes to Chronic Obstructive Pulmonary Disease
Samuel Alam et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Clarification of the Risk of Chronic Obstructive Pulmonary Disease in α1-Antitrypsin Deficiency PiMZ Heterozygotes
Kevin Molloy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
The Circulating Proteinase Inhibitor α-1 Antitrypsin Regulates Neutrophil Degranulation and Autoimmunity
David A. Bergin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
α1-Antitrypsin Modulates Lung Endothelial Cell Inflammatory Responses to TNF-α
Angelia D. Lockett et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Alpha-1 Antitrypsin: A Potent Anti-Inflammatory and Potential Novel Therapeutic Agent
David A. Bergin et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2012)
AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD
Piotr Kuna et al.
RESPIRATORY MEDICINE (2012)
Phase 2 Clinical Trial of a Recombinant Adeno-Associated Viral Vector Expressing α1-Antitrypsin: Interim Results
Terence R. Flotte et al.
HUMAN GENE THERAPY (2011)
The prevalence of alpha-1 antitrypsin deficiency in Ireland
Tomas P. Carroll et al.
RESPIRATORY RESEARCH (2011)
α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8
David A. Bergin et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
CT Scan Appearance, Densitometry, and Health Status in Protease Inhibitor SZ α1-Antitrypsin Deficiency
Jayne Holme et al.
CHEST (2009)
Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options?
Ariel Modrykamien et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Alpha1-Antitrypsin Deficiency
Edwin K. Silverman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
α1-Antitrypsin Augmentation Therapy for PI*MZ Heterozygotes A Cautionary Note
Robert A. Sandhaus et al.
CHEST (2008)
Hereditary alpha-I-antitrypsin deficiency and its clinical consequences
Laura Fregonese et al.
ORPHANET JOURNAL OF RARE DISEASES (2008)
Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ)
H. A. Tanash et al.
THORAX (2008)
Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency
Matthew J. Carpenter et al.
ANNALS OF BEHAVIORAL MEDICINE (2007)
The protease inhibitor PI*S allele and COPD: a meta-analysis
M Dahl et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
α1-Antitrypsin deficiency • 1:: Epidemiology of α1-antitrypsin deficiency
M Luisetti et al.
THORAX (2004)
Z α1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant
AT Mulgrew et al.
CHEST (2004)
American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Cost-effectiveness analysis of augmentation therapy for severe α1-antitrypsin deficiency
TR Gildea et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
A longitudinal study of α1-antitrypsin phenotypes and decline in FEV1 in a community population
GE Silva et al.
CHEST (2003)
Worldwide racial and ethnic distribution of α1-antitrypsin deficiency -: Summary of an analysis of published genetic epidemiologic surveys
FJ de Serres
CHEST (2002)
分享论文
